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Summary
Objectives: Knowledge of matrix assembly is necessary to understand the pathogenesis of disease processes and to find
solutions for repair of articular cartilage lesions. The influence of growth factors on matrix assembly is largely
unknown. We investigated whether, and to what degree, insulin-like growth factor (IGF-1) and transforming growth
factor b-2 (TGFb-2) influence proteoglycan synthesis and accumulation in the cell-associated matrix compartment
(consisting of pericellular and territorial matrix) compared to the further-removed matrix compartment (consisting of
the interterritorial matrix).
Design: Bovine articular chondrocytes were cultured in alginate beads for day 13. The effect of addition of 25 ng/ml
IGF-1 or 25 ng/ml TGFb-2 during the last 7 days in culture was determined. Cell-associated and further-removed matrix
compartments were separated by centrifugation after sodium citrate/EDTA treatment. The amount of DNA, the total
amount of proteoglycans and the amount of newly synthesized proteoglycans were analyzed biochemically.
Morphometric analysis on electron micrographs was used to calculate the volumes of the cell-associated and
further-removed matrix components.
Results: It was demonstrated in control beads that 25 2 8% of the proteoglycans were laid down in the cell-associated
matrix compartment compared with 75 2 8% in the further-removed matrix compartment. The cell-associated matrix
compartment in intact beads could be recognized in electron microscopy by a delineation of dense amorph material.
Morphometric evaluation showed a relative volume of the cell-associated matrix compartment of 5.2 2 0.6% compared
with 91.3 2 0.8% of the further-removed matrix compartment and 3.5 2 0.3% of the area occupied by cells. Combination
of biochemical and morphometric results showed that the concentration of proteoglycans in the cell-associated matrix
compartment was 3.63 2 0.32 mg/ml. By adding IGF-1 or TGFb-2, the amount of both total accumulated proteoglycans
and newly synthesized [35S]proteoglycans at day 13 in culture increased. In addition to an overall rise in proteoglycan
content, IGF-1 significantly increased (24%) the percentage of proteoglycans laid down in the cell-associated matrix
compartment while not changing the relative volume of this compartment (5.2 2 0.8%). This leads to a 82% (P Q 0.05)
increase in the proteoglycan concentration in the cell-associated matrix compartment compared to control beads. In
contrast, TGFb-2 significantly decreased (24%) the relative amount of proteoglycans in the cell-associated matrix
compartment which was paralleled by a reduction of the relative volume from 5.2 2 0.6 to 3.6 2 1.4%. This leads to
a significant increase of 87% of the proteoglycan concentration in the cell-associated matrix compartment.
Conclusions: This study demonstrates that both IGF-1 and TGFb-2 significantly but differently influence
proteoglycan synthesis and accumulation in the cell-associated matrix compartment of cultured bovine chondrocytes
in alginate. Both growth factors increase the concentration of proteoglycans in the cell-associated matrix
compartment. However, addition of TGFb-2 to bovine articular chondrocytes cultured in alginate beads for 13 days
results in a significant reduction of the relative volume of the pericellular matrix compartment compared to controls,
indicating differences in assembly of the matrix.
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Introduction
The unique physicochemical and mechanical
properties of cartilage depend on the composition
of the tissue and its molecular and ultra-structural
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organization. The extracellular matrix of cartilage
can be considered as a compound structure
consisting of a high concentration of proteo-
glycans (PG) embedded in a dense meshwork of
collagen fibres. The predominant PG, aggrecan, is
able to interact with hyaluronic acid and forms
large PG aggregates, which gives cartilage its
ability to resist compressive loads. The assembly of
all molecules together determines the chemically
and mechanically defined cartilage matrix and
provide cartilage with the ability to transmit load
and absorb shocks. Knowledge of matrix assembly
is necessary to understand disease processes like
osteoarthritis and to find solutions for repair of
articular cartilage defects in the future. Although
significant progress has been made in characteriz-
ing novel cartilage molecules, precise morphomet-
ric data on specific matrix compartments in
articular cartilage and the regulatory influence of
growth factors on these compartments are lacking.
Recent evidence on the important but differential
influence of insulin-like growth factor 1 (IGF-1)
and transforming growth factor b (TGFb) on the
expression of chondrocyte integrins and their
adhesion to type VI collagen of the surrounding
pericellular matrix, points to the importance of
these factors in tissue remodelling and repair [1].
Use of TGFb-2 in-vivo has shown to affect cartilage
repair in case of full-thickness defects [2] as well as
the pericellular proteoglycan content of normal
cartilage [3].
When cultured in alginate, chondrocytes have
proven to maintain their cartilaginous phenotype
and produce typical PG aggregates and mainly
collagen type II for a long time [4–6]. Systematic
morphometric analysis of cell and matrix volumes
of human articular chondrocytes cultured at a
density of 8 million cells/ml of alginate for 30 days,
revealed a striking similarity to values obtained
for age-and sex-matched articular cartilage biop-
sies from the same topographical area of the joint
[7]. In articular cartilage, the pericellular matrix
around the chondrocyte and the territorial matrix
lying next to it form the cell-associated matrix
compartment [8, 9]. Interestingly, the extracellular
matrix of chondrocytes cultured in alginate is
composed of these two compartments too: the
cell-associated matrix (CM), believed to corre-
spond to the pericellular and territorial matrix
compartments, previously identified in articular
cartilage by electron microscopy [8] and the
further-removed matrix (FRM), that is thought to
correspond to the interterritorial areas of the
articular cartilage [9]. Lohmander [10] was the first
to propose that the cartilage matrix contains at
least two compartments of proteoglycans, turning
over at different rates, a hypothesis supported by
his study of guinea-pig costal cartilage. Evidence
in support to this contention was recently obtained
from a study which compared the rate of turnover
of aggrecan molecules present in the cell-associ-
ated and further-removed compartments of the
matrix formed by mature bovine articular chondro-
cytes in alginate beads [9]. Because the alginate
culture system gives the opportunity to differen-
tiate between the combined pericellular/territorial
( = CM) and the interterritorial ( = FRM) matrix
[5, 7, 9] it provides an important system to study
assembly of PG in different matrix compartments.
The important growth factors known to be able
to stimulate PG synthesis are IGF-1 and TGFb
[11–17]. However, not much is known about their
influence on matrix assembly of PG and other
matrix molecules, a fact which according to recent
results shown by Loeser [1] is probably much more
important than the mere fact, that there is a
stimulation of PG synthesis.
In this paper we report our biochemical and
morphometrical investigations of the effects of
IGF-1 and TGFb-2 on PG synthesis and accumu-
lation in the two matrix compartments (CM and
FRM) of bovine articular chondrocytes cultured in
alginate.
Materials and Methods
chondrocyte culture in alginate
Metacarpophalangeal (MCP) joints of steers
(14–18 months old) were obtained from the
slaughterhouse. Full-thickness cartilage slices
were aseptically collected and washed with
physiological saline. In all experiments cartilage of
at least two MCP-joints was pooled to reduce
potential individual variation. Slices were incu-
bated for 1–1.5 h with pronase E (2 mg/ml; Sigma,
St. Louis, MO, U.S.A.) followed by overnight
incubation with collagenase B (1.5 mg/ml, 50 ml/
joint; Boehringer Mannheim, Germany) in medium
with 10% fetal calf serum (FCS). Undigested parts
were removed using a 100 mm filter. Isolated
chondrocytes were washed with physiological
saline. Cell viability was tested using the trypan
blue exclusion test.
Isolated cells were encapsulated in alginate
beads at a density of 8 · 106 cells/ml of gel. The
preparation of chondrocytes in alginate beads was
performed as described by Guo et al. [4], with slight
modifications described by Ha¨uselmann et al. [5].
Briefly, the cells were suspended in sterile saline
containing 1.2% low-viscosity alginate gel (Kel-
tone LV, Kelco, Chicago, IL, U.S.A.), then slowly
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pressed through a 22 gauge needle in a dropwise
fashion into a 102 mm CaCl2 solution. After
instantaneous gelation the beads were allowed to
polymerize further for a period of 10 min in the
CaCl2 solution. They were thereafter washed with
saline and finally placed in Ham’s F12/Delbecco’s
modified Eagle’s medium (DMEM) medium (Gibco,
Grand Island, NY, U.S.A.) supplemented with 10%
FCS, 50 mg/ml gentamicin and 25 mg/ml l-ascorbic
acid freshly added (Sigma, St. Louis, MO, U.S.A.).
Five beads (18 ml/bead) were cultured in 0.5 ml
medium in each well of a 24-well plate. The medium
was changed daily.
After 6 days one third of the beads remained on
medium plus 10% FCS, one third were supplied
daily with 25 ng/ml rhIGF-1 (Sandoz, Switzerland)
and one third with 25 ng/ml rhTGFb-2 (Sandoz,
Switzerland) and cultured for another week.
release of cells with their cm from the beads
Five beads were dissolved by adding 450 ml of
55 mm sodium citrate and 20 mm EDTA in 150 mm
NaCl for 10 min at room temperature. The
suspension was centrifuged 10 min at 1000 rpm in
an Eppendorf centrifuge, to separate the cells
surrounded by CM (the pellet) from components
originating predominantly from the ‘interterrito-
rial’ matrix further removed from the cells (FRM;
the supernatant) [5]. However, we can not
completely rule out the possibility that matrix
constituents from the other matrix component
were present in smaller amounts.
determination of the amount of dna
Papain (Sigma, St. Louis, MO, U.S.A.) was added
to the sodium-citrate/EDTA dissolved beads to a
final concentration of 125 mg/ml in a volume of
900 ml and incubated overnight at 60° C. The
amount of DNA in the beads was measured using
Hoechst 33258 dye [18] and compared with calf
thymus DNA (Sigma, St Louis, MO, U.S.A.).
Extinction (365 nm) and emission (440 nm) were
measured with a spectrofluorometer (RF-5001 PC,
Shimadzu, Japan).
quantification of glycosaminoglycans (gags)
in different compartments of the alginate
bead
After separation of CM and FRM, GAG was
extracted with 4 m GuHCl (in 0.05 m sodium-acet-
ate buffer containing 0.1 m 6-aminocaproic acid,
0.02 m EDTA, 2.5 mm benzamidine HCl, 5 mm NEM,
0.25 mm PMSF) for 48 h at 4° C (total volume
900 ml).
The amount of GAG in CM and FRM was
quantified using the Farndale assay [19]. In short,
the metachromatic reaction of GAG with dimethyl-
methylene blue is monitored using a spectropho-
tometer. The ratio A530:A590 is used to calculate the
amount of GAG in the samples. Chondroitin
sulfate C (Shark; Sigma) was used as a standard. In
the standard curve, corrections are made for the
possible effects of solubilizing agents, extractants
and remnants of alginate.
quantification of [35s]sulfate-labeled
proteoglycans in different compartments
of the alginate bead
In order to investigate whether effect of growth
factors on the distribution of PG in CM and FRM
is caused by different assembly of PG, the
distribution of newly synthesized [35S]PG is
studied.
In preparation for the 16 h labeling period with
0.74 MBq/ml [35S]sulfate (Du Pont de Nemours,
’s-Hertogenbosch, the Netherlands) the beads were
placed in new 24-well plates at day 12 of culture,
in order to avoid the labeling of a heterogenous
cell population due to the formed monolayer at the
bottom of wells. After labeling the beads were
washed with saline. The matrix was divided in CM
and FRM and PG were extracted with GuHCl as
described above.
After extraction, PG were precipitated with
0.1% cetylpyridinium chloride (CPC) at 37° C for at
least 2 h. The resulting pellet was washed with
0.05% CPC to remove any remaining glycopeptides
and unincorporated precursors. To control the
efficiency of removal of unincorporated precursor
the last wash step had to contain less than 100 cpm.
Each pellet was then supplemented with 0.5 ml
Luma solve (Hicol, Oud-Beijerland, the Nether-
lands) and the [35S]PG quantified with liquid
scintillation counting.
transmission electron microscopy
For electron microscopical analysis, beads were
prefixed for 24 h with 2% glutaraldehyde and 2%
tannic acid in 0.1 m sodium cacodylate (pH 7.4) to
which 10 mm CaCl2 was added to prevent disinte-
gration of the beads. After washing in 0.1 m sodium
cacodylate buffer, the beads were postfixed with
1% OsO4 in 0.1 m sodium cacodylate for 1 h,
washed, dehydrated in ethanol and embedded in
Epon 812 [7]. Thin sections ( 1 60 nm) were stained
with 2% ethanolic uranyl acetate and aqueous lead
citrate and examined in a Hitachi H7100-B
transmission electron microscope.
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Morphometrical analysis
Each of the control, IGF-1 and TGFb-2 treated
groups contained five beads for electron mi-
croscopy. Ten sections of each bead were analyzed
and from each section 10 photomicrographs were
taken by a systematic random sampling protocol,
and volume densities of matrix compartments
determined morphometrically by point counting
procedures [20]. The average of the micrographs of
the 10 sections were calculated to obtain one value
for each bead. Mean and standard deviation of five
beads were calculated and presented.
To validate that the two matrix pools by EM and
sodium citrate/EDTA extraction map the same
pools cells, cells were released from the alginate by
sodium citrate/EDTA extraction, pelleted and
fixed and stained for EM. These experiments
showed that the cells and the CM go along the
lines of the fibrous-basket like structures seen with
EM on undamaged alginate beads (unpublished
results).
calculation of gag concentration
Using the determined GAG amount from the
Farndale assay and the volume of CM and FRM
from EM-morphometry, the concentration of GAG
was calculated. Shrinkage (20%) due to dehy-
dration and embedding [20] was accounted for to
calculate FRM volume. Shrinkage of the cells and
CM was negligible.
Based on the distribution of volumes occupied by
cells, CM and FRM and knowing the volume of an
alginate bead (18 ml), the volume occupied by CM
and FRM was determined in microliters. From the
Farndale assay, the amount of GAG was known
in micrograms. Therefore we could calculate
the concentration of GAG in CM and FRM in
micrograms per microliter.
statistical analysis
For the biochemical measurements, three exper-
iments each consisting of three groups of five beads
for measurements were performed. The paired
Student’s t-test was used for statistical analysis.
For the morphometrical measurements, we used 5
beads per group from one experiment. The
unpaired t-test was used for statistical analysis.
P Q 0.05 was considered statistically significant.
Results
growth factor dose
Using 0.25, 2.5 and 25 ng/ml of growth factor in
a pilot experiment, we could demonstrate a dose
response of GAG synthesis and total amount of
GAG. For both growth factors 0.25 ng/ml had no
effect and the highest responses were found with
25 ng/ml (data not shown). Therefore this concen-
tration was used for further studies.
the amount of dna
Each bead contained an average of 3.3 mg DNA.
According to published values [18] for DNA
content per cell (7.7 pg DNA/cell), each bead
contains 4.3 · 105 cells at day 13 of the experiment.
Comparing this cell number with the initial
number of chondrocytes after their suspension in
alginate (1.4 · 105 cells/bead), a threefold increase
in cell number could be demonstrated during 13
days of culture. This is in agreement with our
previous experiments [5]. No significant differ-
ences in the amount of DNA could be shown if
growth factors were added (Fig. 1), indicating that
IGF and TGFb had no effect on cell proliferation
in our system.
the amount of gag
Control beads contained 15.3 mg GAG after 13
days. The amount of GAG increased by 43% under
the influence of IGF-1 and by 62% if TGFb-2 was
added [Fig. 2(a)]. In addition to calculation of the
amount of GAG per bead, the amount of GAG per
DNA was calculated. The amount of GAG per
micrograms of DNA in control beads was
4.8 2 1.9 mg GAG/mg DNA and this was increased
Fig. 1. The amount of DNA (mg) 2 s.e.m. per bead after
13 days in culture, the last 7 days in the presence of
25 ng/ml IGF-1 or TGFb-2. Means of three experiments
with five beads are presented. (Q) Control; (-) IGF-1;
(;) TGFb-2.
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Fig. 2. (a) The total amount of glycosaminoglycan (GAG)
(mg) 2 s.e.m. per bead after 13 days in culture, the last 7
days in the presence of 25 ng/ml IGF-1 or TGFb-2. Means
of three experiments with five beads are presented. (Q)
Control; (<) IGF-1; (;) TGFb-2. (b) Percentage of total
accumulated GAG in the cell-associated matrix in
relation to control cultures. The percentage of GAG in
control beads was 25% 2 8. For each of the three
experiments the percentage in the control beads is set at
100%. (<) IGF-1; (;) TGFb-2.
with regard to the newly synthesized [35S]PG
[Fig. 3(a)] at day 13 in culture. IGF-1 increased the
percentage of newly synthesized [35S]PG in the CM
from 39% in control beads to 47% (21% increase)
[Fig 3(b)]. In contrast TGFb-2 decreased this
percentage of [35S]PG in the CM from 39% in the
control beads to 29% (26% decrease) [Fig. 3(b)].
With respect to the distribution of newly
synthesized [35S]PG in the two compartments of the
matrix (CM vs FRM) the percentage of newly
synthesized [35S]PG in the CM was somewhat
higher than the total accumulated GAG (39 vs
25%).
Fig. 3. (a) The amount of newly synthesized [35S]PG
during a 16 h pulse at day 13 of culture. The last 7 days
of culture the chondrocytes were daily fed with addition
of 25 ng/ml IGF-1 or TGFb-2. Means 2 s.e.m. of three
experiments with five beads are presented. (Q) Control;
(<) IGF-1; (;) TGFb-2. (b) Percentage of [35S]PG located
in the cell-associated matrix in relation to control
cultures. The percentage of [35S]PG in control beads was
39% 2 8. For each of the three experiments the
percentage in the control beads is set at 100%. (<)
IGF-1; (;) TGFb-2.
by IGF (6.7 2 1.5 mg/mg DNA) and TGFb
(7.1 2 0.2 mg/mg DNA).
In control beads, 25% of the GAG was located in
the CM and 75% in the FRM compartment.
Compared with control beads the percentage of
cell-associated GAG was significantly increased
with IGF-1 (from 25 to 31%; an increase of 24%)
and decreased with TGFb-2 (from 25 to 19%; a
decrease of 24%) [Fig. 2(b)].
synthesis of [35s]pg
The same behaviour as demonstrated with the
amount of ‘cold’, non-radioactive accumulated
GAG over time in culture, could be demonstrated
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Fig. 4. Electron micrographs of bovine articular cartilage chondrocytes cultured in alginate beads. Control
chondrocyte (a), as well as those stimulated with IGF-1 (b), or TGF-b2 (not illustrated), are surrounded by matrix
material, which is typically organized into zones: a narrow pericellular mantle (delineated by arrowheads), gives way
to a broader territorial coat [(T); outer boundary indicated by solid dots] which, in turn, is surrounded by a
‘further-removed’ compartment (FRM) that extends almost imperceptibly into the alginate scaffolding. The pericellular
matrix bounds in microvilli, protruding from the chondrocyte surface and is also rich in electron-dense clumps of
unknown nature. The territorial matrix is characterized by a fine granular appearance, wherase the ‘further-removed’
one manifests a coarse reticular pattern with scattered electron-dense precipitates (of unknown nature;
electron-diffraction negative). Morphometric analysis reveals that the average volumes of the pericellular and
territorial matrix compartments surrounding control- and IGF-1 stimulated chondrocytes are larger than those
associated with TGFb-2 treated ones. Magnification: (a): bar = 3 mm. (b): bar = 1 mm.
electron microscopy
The cells in alginate showed a spherical
morphology in the centre of the bead. Cells of the
periphery were more elongated. The beads con-
tained mostly single cells although sometimes
small clusters, containing about 3–5 cells, were
seen as well. Due to a denser accumulation of
amorphous material in the CM compartment a
delineation from the FRM is possible (Fig. 4).
Morphological examination revealed [Table 1]
that addition of growth factors had no signifi-
cant effect on the volume occupied by the
cells. The compartment of CM however, was
significantly smaller around cells treated with
TGFb. The concentration of electron dense
Table I
Relative volumes of cells, CM and FRM and the concentration of PGs in CM and
FRM
Relative Relative Relative PGs in
volume cells volume CM volume PGs in CM FRM
(%) (%) FRM (%) (mg/ml) (mg/ml)
Control 3.5 2 0.33 5.2 2 0.6 91.3 2 0.8 3.6 2 1.0 0.7 2 2.8
IGF-1 4.2 2 0.46 5.2 2 0.8 90.6 2 1.4 6.6 2 2.9* 1.0 2 4.2
TGF-b2 4.2 2 0.80 3.6 2 1.4** 92.3 2 2.4 6.8 2 1.7* 1.2 2 3.0
The relative volumes of cells\ CM and FRM were quanti_ed using electron microscopy morphometry[
The concentration of PG is calculated by combining the results of the Farndale assay and the volumes
of CM and FRM[
CM\ cell!associated matrix^ FRM\ further!removed matrix[
PQ 9[94^ P Q 9[990[
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material appeared higher. There were no differ-
ences visible between control and IGF-1 treated
beads.
From the combined biochemical and morphomet-
ric data, the concentrations of PG in both the CM
and the FRM compartment were determined.
Neither IGF-1 nor TGFb-2 had a significant effect
on the concentration of PG in the FRM compart-
ment. However, both growth factors appeared to
increase significantly the concentration of PG in
the CM compartment [Table 1].
Discussion
In this study we focused on the influence of two
important growth factors, IGF-1 and TGFb-2 on
newly synthesized and total PG and their influence
on volumes of two different matrix compartments
in bovine chondrocytes cultured in alginate for 13
days, using conventional biochemical methodology
and exact quantitative morphometrical character-
ization by electron microscopy. As demonstrated
earlier by others and recently by our group using
the novel alginate culture system [6, 21–24] the
majority of newly synthesized aggrecan molecules
will during matrix assembly spend a relatively
short time in the cell-associated matrix before
moving into the further-removed matrix, where
they eventually become incorporated into aggre-
gates. The use of alginate as culture system seems
to be advantageous for this type of studies, because
of three main reasons. First, the cells maintain
their phenotype, resulting in production of
collagen type II and aggrecan [4, 6]. Second, the
beads can easily be disintegrated using a chelator
and after a gentle centrifugation, cells with their
pericellular matrix will separate from the further-
removed matrix compartment [7]. Third, we have
demonstrated previously that human articular
chondrocytes, cultured at a density of 8 million
cells/ml of alginate for 30 days, revealed cell- and
matrix volumes as well as a PG concentration in
the CM compartment strikingly similar to values
obtained for age- and sex-matched articular
cartilage biopsies from the same topographical
area of the knee joint [7]. By using the two growth
factors IGF-1 and TGFb-2 in this well character-
ized model, we were able to study their role in PG
synthesis and matrix assembly.
The definition of the effect of IGF-1 and TGFb-2
on the structure and function of the cartilage
matrix as a whole is of critical importance for our
understanding of cartilage physiology and poten-
tial therapeutic use. In general, IGF is known as
anabolic factor and stimulates proliferation and
cartilage formation [12, 17, 25]. TGFb however, has
been found to be able to have both stimulating
and inhibitory effects [15–17, 25–32]. Differential
effects of different TGFb subtypes are not well
known, and Morales [31] described no differences
between the effects of TGFb-1, -2 and -3 on PG
synthesis in bovine cartilage. In our study, we
could demonstrate that both IGF-1 and TGFb-2
lead to a stimulation of PG synthesis. These newly
synthesized PG were differently laid down in CM
or FRM, depending on the growth factor used. The
distribution in CM and FRM was comparable for
newly synthesized [35S]PG and total PG. This
indicates that the differential effect of growth
factors is a differential effect on PG assembly and
not on PG degradation. Treatment of bovine
chondrocytes in alginate for 7 days with 25 ng/ml
TGFb-2, in contrast to IGF-1, not only decreased
the relative amount of PG residing in the CM
compartment as compared to the FRM compart-
ment, but also unexpectedly lead to a decrease of
the matrix volume occupied by the CM compart-
ment, as shown by the corresponding morphometri-
cal analysis. To our knowledge this is the first
report demonstrating that the addition of TGFb to
bovine articular chondrocytes cultured in alginate
beads for 13 days results in a significant reduction
of the relative volume of the pericellular matrix
compartment compared to controls.
Cartilage matrix is mainly composed of collagen
type II and aggrecan. In addition, small PG
(biglycan, decorin, fibromodulin), other glyco-
proteins (fibronectin), other collagen types (type
VI, IX and XI) and non-collagenous matrix proteins
(e.g., cartilage oligomeric matrix protein, COMP)
are present. All these molecules are important but
not well-characterized factors for matrix assembly.
The relation between small PG and collagen seems
to play a crucial role in matrix assembly. Biglycan
is mainly found in the pericellular matrix and is
thought to interact with collagen VI which is
bound to the cell surface. Decorin is thought to
play a role in fibrillogenesis. Roughley et al. [33]
showed that TGFb increased the synthesis of
biglycan and decreased that of decorin, whereas
IGF had no effect. By these effects TGFb may affect
matrix assembly. As published by several groups
[1, 7, 34] surface receptors of chondrocytes (CD44,
integrins, COMP) bind to several components of
pericellular matrix and therefore are important
factors for matrix assembly. Recent evidence
shown by Loeser [1] points to the importance of
growth factors and their differential effects on
integrin expression on chondrocytes. In contrast to
IGF-1, TGFb decreased cell surface levels of a1b1
integrins. TGFb was also able to induce a
decreased adhesion of chondrocytes to collagen
van Osch et al.: Growth factors and proteoglycan assembly194
type VI, which plays an important role for the
assembly of pericellular matrix in cartilage. These
results point to a possible inhibitory function of
TGFb regarding the assembly of the pericellular
matrix and may explain our findings of a reduced
volume of the CM compartment in cultured bovine
chondrocytes by TGFb compared to IGF-1 and
control.
In the light of our findings it is worth noting the
published results of van Beuningen et al. [3] and
van den Berg et al. [35], who showed an enhanced
loss of PG in the middle layers of mouse femoral
cartilage after intra-articular injection of TGFb
(but not IGF-1). Further studies are needed to
clarify the function and effects of growth factors,
and especially TGFb-2, in matrix assembly and to
study whether these effects result in cartilage of
different mechanical properties, and a different
vulnerability for degradation.
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